Grupo México, S.A.B. de C.V. (GMBXF)
OTCMKTS · Delayed Price · Currency is USD
6.28
-0.22 (-3.38%)
Aug 1, 2025, 2:54 PM EDT
Verve Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 3,888 | 3,615 | 3,375 | 3,147 | 3,954 | 2,280 | Upgrade |
Depreciation & Amortization | 1,338 | 1,348 | 1,201 | 1,069 | 1,039 | 990.62 | Upgrade |
Other Amortization | 97.8 | 97.8 | 54.9 | 61.3 | 71.7 | 42.7 | Upgrade |
Loss (Gain) From Sale of Assets | 44.43 | 29.2 | 81.78 | 31.16 | 21.38 | 28.86 | Upgrade |
Asset Writedown & Restructuring Costs | 0.02 | 0.02 | 0.01 | 0 | 4.4 | - | Upgrade |
Loss (Gain) From Sale of Investments | - | - | - | -15.91 | 304.23 | -318.29 | Upgrade |
Loss (Gain) on Equity Investments | -25.52 | -18.39 | -17.86 | 6.71 | -16.49 | -2.87 | Upgrade |
Other Operating Activities | 106.77 | 1,680 | 997.54 | 245.25 | 1,248 | 1,177 | Upgrade |
Change in Accounts Receivable | 58.65 | -118.61 | 216.43 | -142.7 | -285.27 | -276.37 | Upgrade |
Change in Inventory | -8.45 | -4.51 | -74.53 | -44.19 | 39.72 | 354.1 | Upgrade |
Change in Accounts Payable | 72.24 | 36.55 | 8.3 | 142.04 | 41.38 | -50.28 | Upgrade |
Change in Other Net Operating Assets | 47.3 | -663.22 | -26.92 | 198 | -48.48 | 138.82 | Upgrade |
Operating Cash Flow | 5,619 | 6,002 | 5,815 | 4,697 | 6,374 | 4,365 | Upgrade |
Operating Cash Flow Growth | 23.47% | 3.21% | 23.80% | -26.30% | 46.02% | 32.84% | Upgrade |
Capital Expenditures | -1,894 | -1,766 | -1,661 | -1,542 | -1,362 | -1,115 | Upgrade |
Sale of Property, Plant & Equipment | - | - | 1.22 | 3.17 | 7.99 | 6.44 | Upgrade |
Cash Acquisitions | -1,306 | - | -248.21 | - | - | - | Upgrade |
Investment in Securities | 838.98 | 838.98 | -1,443 | 389.76 | 614.83 | 278.61 | Upgrade |
Investing Cash Flow | -2,505 | -927.02 | -3,351 | -1,149 | -739.09 | -829.65 | Upgrade |
Long-Term Debt Issued | - | 315.92 | 27.55 | - | 361.39 | 269.34 | Upgrade |
Long-Term Debt Repaid | - | -567.26 | -350.77 | -614.61 | -599.99 | -730.94 | Upgrade |
Net Debt Issued (Repaid) | 544.06 | -251.34 | -323.22 | -614.61 | -238.6 | -461.6 | Upgrade |
Issuance of Common Stock | 448.29 | 448.29 | - | - | - | - | Upgrade |
Repurchase of Common Stock | - | - | -42.55 | -33.59 | -10.49 | -14.63 | Upgrade |
Common Dividends Paid | -1,896 | -1,809 | -1,685 | -1,941 | -2,359 | -1,059 | Upgrade |
Other Financing Activities | -669.1 | -990.49 | -1,160 | -1,056 | -1,064 | -826.67 | Upgrade |
Financing Cash Flow | -1,573 | -2,602 | -3,210 | -3,645 | -3,671 | -2,362 | Upgrade |
Foreign Exchange Rate Adjustments | -139.51 | -100.31 | -87.13 | -104.39 | 329.17 | -15.57 | Upgrade |
Net Cash Flow | 1,402 | 2,372 | -833.32 | -201.5 | 2,293 | 1,158 | Upgrade |
Free Cash Flow | 3,725 | 4,236 | 4,154 | 3,155 | 5,012 | 3,250 | Upgrade |
Free Cash Flow Growth | 32.44% | 1.97% | 31.67% | -37.05% | 54.20% | 50.47% | Upgrade |
Free Cash Flow Margin | 22.70% | 26.20% | 28.92% | 22.75% | 33.92% | 29.80% | Upgrade |
Free Cash Flow Per Share | 0.48 | 0.54 | 0.53 | 0.41 | 0.64 | 0.42 | Upgrade |
Cash Interest Paid | 575.54 | 575.54 | 562.14 | 535.77 | 549.76 | 557.45 | Upgrade |
Cash Income Tax Paid | 1,970 | 1,970 | 1,836 | 2,665 | 2,253 | 1,222 | Upgrade |
Levered Free Cash Flow | 3,725 | 3,862 | 3,089 | 1,955 | 4,400 | 2,649 | Upgrade |
Unlevered Free Cash Flow | 4,077 | 4,222 | 3,441 | 2,290 | 4,744 | 2,992 | Upgrade |
Change in Net Working Capital | -61.41 | -235.84 | -172.85 | 1,024 | -100.09 | -384.89 | Upgrade |
Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.